Drug Pricing Uncertainty Results In Risk To Core Forecast Scenario

BMI View: Current disputes between pharmaceutical industry associations and the Czech government has created uncertainty for BMI's pharmaceutical expenditure forecast scenario. By extension, this has added to the level of risk associated with the Czech market due to uncertainty surrounding the continuation or addition of further drug pricing reforms.

To read the full article, please choose one of the following options: